Abstract
AN insight into the biochemical strategy of cancer cells has been achieved by the conceptual and experimental approach provided by the molecular correlation concept1,2. Studies carried out using this approach with model systems of rat hepatomas and kidney tumours of different growth rates revealed a biochemical imbalance in cancer cells, which manifested itself in progressive changes in activities of key enzymes and overall metabolic pathways that correlated with tumour growth rate1,2. Some of these biochemical alterations have been shown to apply to human primary liver3 and kidney4 carcinomas. Those alterations in gene expression that are linked to the increase in the expression of malignancy are manifested in the increased activities of key glycolytic-, purine-, pyrimidine-, DNA- and polyamine-synthesising enzymes1–8. Concurrently, decreases occur in the activities of the key enzymes of gluconeogenesis, purine and pyrimidine catabolism and of the urea cycle1–5,9,10. In addition to such a progression-linked (growth-rate-linked) metabolic imbalance, the reprogramming of gene expression in cancer cells entails transformation-linked alterations that are present in all hepatomas irrespective of growth rate or extent of differentiation1,2,11–15.Here we report that CTP synthetase (UTP:L-glutamine amido ligase, EC 6.3.4.2) increased in all the hepatomas examined, the activity being highest in the rapidly growing tumours. Thus, in liver neoplasia the activity of this enzyme is both transformation- and progression-linked. CTP synthetase activity was also markedly increased in transplantable kidney tumours in the rat and in primary renal cell carcinomas in man.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weber, G. N. Engl. J. Med. 296, 486–493 (1977).
Weber, G. N. Engl. J. Med. 296, 541–551 (1977).
Weber, G., Prajda, N. & Jackson, R. C. Adv. Enz. Regul. 14, 3–24 (1976).
Weber, G. et al. in Biological Characterisation of Human Tumours (eds Davis, W. & Maltoni, C.) 60–72 (Excerpta Medica, Amsterdam. 1976).
Weber, G., Goulding, F. J., Jackson, R. C. & Eble, J. N. in Biological Characterisation of Human Tumours (eds. Davis, W. & Maltoni, C.) (Excerpta Medica, Amsterdam, in the press).
Jackson, R. C., Weber, G. & Morris, H. P. Nature 256, 331–333 (1975).
Elford, H. L., Freese, M., Passamani, E. & Morris, H. P. J. biol. Chem. 245, 5228–5233 (1970).
Williams-Ashman, H. G., Coppoc, G. L. & Weber, G. Cancer Res. 32, 1924–1932 (1972).
Queener, S. F., Morris, H. P. & Weber, G. Cancer Res. 31, 1004–1009 (1971).
Weber, G., Queener, S. F. & Morris, H. P. Cancer Res. 32, 1933–1940 (1972).
Weber, G., Jackson, R. C., Williams, J. C., Goulding, F. J. & Eberts, T. J. Adv. Enz. Regul. 15, 53–77 (1977).
Heinrich, P. C., Morris, H. P. & Weber, G. Cancer Res. 36, 3189–3197 (1976).
Prajda, N., Katunuma, N., Morris, H. P. & Weber, G. Cancer Res. 35, 3061–3068 (1975).
Prajda, N., Morris, H. P. & Weber, G. Cancer Res. 36, 4639–4646 (1976).
Williams, J. C., Morris, H. P. & Weber, G. Nature. 253, 567–569 (1975).
Jackson, R. C., Boritzki, T. J., Morris, H. P. & Weber, G. Life Sci. 19, 1531–1536 (1976).
McPartland, R. P., Wang, M. C., Bloch, A. & Weinfeld, H. Cancer Res. 34, 3107–3111 (1974).
Sweeney, M. J., Parton, J. W. & Hoffman, D. H. Adv. Enz. Regul. 12, 385–396 (1974).
Weber, G. et al. Adv. Enz. Regul. 16, (in the press).
Bucher, N. L. R. & Malt, R. A. Regeneration of Liver and Kidney (Little Brown, Boston, 1971).
Neuhard, J., Randerath, E. & Randerath, K. Analyt. Biochem. 13, 211–222 (1965).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. J. biol. Chem. 193, 265–275 (1951).
Jackson, R. C., Williams, J. C. & Weber, G. Cancer Treatment Rep. 60, 835–843 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
WILLIAMS, J., KIZAKI, H., WEBER, G. et al. Increased CTP synthetase activity in cancer cells. Nature 271, 71–73 (1978). https://doi.org/10.1038/271071a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/271071a0
This article is cited by
-
Inactivation of cytidine triphosphate synthase 1 prevents fatal auto-immunity in mice
Nature Communications (2024)
-
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
Journal of Translational Medicine (2022)
-
A novel 14-gene signature for overall survival in lung adenocarcinoma based on the Bayesian hierarchical Cox proportional hazards model
Scientific Reports (2022)
-
Ectopic miR-975 induces CTP synthase directed cell proliferation and differentiation in Drosophila melanogaster
Scientific Reports (2019)
-
Pleiotropic mutants of Chinese hamster cells with altered cytidine 5?-triphosphate synthetase
Biochemical Genetics (1984)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.